These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 3265070

  • 1. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
    Hollinden GE, Sanchez-Ramos JR, Sick TJ, Rosenthal M.
    Brain Res; 1988 Dec 20; 475(2):283-90. PubMed ID: 3265070
    [Abstract] [Full Text] [Related]

  • 2. 1-Methyl-4-phenylpyridinium (MPP+) increases oxidation of cytochrome-b in rat striatal slices.
    Sanchez-Ramos JR, Hollinden GE, Sick TJ, Rosenthal M.
    Brain Res; 1988 Mar 08; 443(1-2):183-9. PubMed ID: 3258785
    [Abstract] [Full Text] [Related]

  • 3. Selective and nonselective effects of 1-methyl-4-phenylpyridinium on oxygen consumption in rat striatal and hippocampal slices.
    Martin FR, Sanchez-Ramos J, Rosenthal M.
    J Neurochem; 1991 Oct 08; 57(4):1340-6. PubMed ID: 1895108
    [Abstract] [Full Text] [Related]

  • 4. MPP+-induced pathophysiology demonstrates advantages of neurotoxicology studies in brain slices.
    Hollinden GE, Sanchez-Ramos JR, Sick TJ, Rosenthal M.
    J Neurosci Methods; 1989 May 08; 28(1-2):51-7. PubMed ID: 2786117
    [Abstract] [Full Text] [Related]

  • 5. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 6. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
    Snape BM, Pileblad E, Ekman A, Magnusson T, Carlsson A, Engel J.
    J Pharm Pharmacol; 1988 Sep 08; 40(9):620-6. PubMed ID: 2907028
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC.
    Neurosci Lett; 1985 Dec 18; 62(3):389-94. PubMed ID: 3912685
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
    Vyas I, Heikkila RE, Nicklas WJ.
    J Neurochem; 1986 May 18; 46(5):1501-7. PubMed ID: 3485701
    [Abstract] [Full Text] [Related]

  • 11. Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique.
    Ozaki N, Nakahara D, Kaneda N, Kiuchi K, Okada T, Kasahara Y, Nagatsu T.
    J Neural Transm; 1987 May 18; 70(3-4):241-50. PubMed ID: 3500274
    [Abstract] [Full Text] [Related]

  • 12. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver.
    Thakar JH, Hassan MN, Grimes JD.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 May 18; 12(2-3):355-62. PubMed ID: 3260387
    [Abstract] [Full Text] [Related]

  • 13. Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice.
    Sundström E, Goldstein M, Jonsson G.
    Eur J Pharmacol; 1986 Nov 19; 131(2-3):289-92. PubMed ID: 3493159
    [Abstract] [Full Text] [Related]

  • 14. MPTP, MPP+ and mitochondrial function.
    Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE.
    Life Sci; 1987 Feb 23; 40(8):721-9. PubMed ID: 3100899
    [Abstract] [Full Text] [Related]

  • 15. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P, Nicklas WJ, Ofori S, Shen J, Mytilineou C.
    J Neurochem; 1989 Oct 23; 53(4):1149-55. PubMed ID: 2788714
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
    Mayer RA, Kindt MV, Heikkila RE.
    J Neurochem; 1986 Oct 23; 47(4):1073-9. PubMed ID: 3489072
    [Abstract] [Full Text] [Related]

  • 18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S, Zuddas A, Kopin IJ, Barker JL, di Porzio U.
    J Neurochem; 1988 Jun 23; 50(6):1900-7. PubMed ID: 3259619
    [Abstract] [Full Text] [Related]

  • 19. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A, Fascetti F, Corsini GU, Piccardi MP.
    Exp Neurol; 1994 May 23; 127(1):54-61. PubMed ID: 8200437
    [Abstract] [Full Text] [Related]

  • 20. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
    Sirinathsinghji DJ, Heavens RP, Richards SJ, Beresford IJ, Hall MD.
    Neuroscience; 1988 Oct 23; 27(1):117-28. PubMed ID: 3264391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.